Success Metrics

Active Trials
3(100%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

3

all time

Status Distribution
Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials
Showing 3 of 3
recruitingnot_applicable

Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)

NCT06464926
recruitingnot_applicable

Study of Enterra Programming with Nocturnal Cycling in Gastroparetics

NCT05980455
recruitingnot_applicable

Study of Enhanced Programming Stimulation with the Enterra® Therapy System

NCT06560307

Clinical Trials (3)

Showing 3 of 3 trials
NCT06464926Not Applicable

Chronic Nausea and Vomiting in Patients With Normal Gastric Emptying Using the Enterra® Therapy System (NAVIGATE)

Recruiting
NCT05980455Not Applicable

Study of Enterra Programming with Nocturnal Cycling in Gastroparetics

Recruiting
NCT06560307Not Applicable

Study of Enhanced Programming Stimulation with the Enterra® Therapy System

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
3